Endometrial carcinoma expresses an increased cathepsin B/D ratio

William H. Bradley, Paul H. Lima, Lisa Rodgers, Charles H. Blomquist, Levi S Downs

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Objectives.: Cathepsins B and D belong to a family of proteases involved in tumor invasion and metastasis. As such they may function as biomarkers for the aggressiveness of a given tumor. We examined the enzymatic activity of these proteins as well as the cellular and extracellular distribution of cathepsins B and D. Methods.: 39 snap frozen tissue samples were assayed for activity fluorometrically with cathepsin-specific peptide substrates in combination with specific inhibitors. 4 groups were established: benign tissue, stage I/grade 1, stage i/grade 3, and stage IIIC/any grade. IHC staining for cathepsin B with the percentage of counterstained enzyme calculated from each specimen. Results.: A significantly increased level of cathepsin B activity was seen in malignant tissue specimens when compared to benign tissue. The cathepsin B/D ratio confirmed and was required to detect the significance of this distinction for each malignant group when compared to benign samples. There were no differences in cathepsin B or D expression detected between the various malignant groups. IHC staining for cathepsin B was more diffuse in the malignant tissues. Conclusions.: Malignant endometrium displays increased cathepsin B activity when compared benign samples. The cathepsin B/D ratio is increased for each of the malignant groups studied when compared directly to benign endometrium. The cathepsin B/D ratio cannot be utilized to distinguish the stage or grade between any of the malignant groups studied. This ratio may serve to distinguish malignant from benign tumor samples and may be a constitutive change in the malignant transformation.

Original languageEnglish (US)
Pages (from-to)84-89
Number of pages6
JournalGynecologic oncology
Issue number1
StatePublished - Jan 2008

Bibliographical note

Funding Information:
This work has been supported by a Grant from the University of Minnesota Women's Health Fund's Fritz and Mary Corrigan Fund (WHB) and by The Robert Wood Johnson Foundation's Harold Amos Faculty Development Award, #043487 (LSD).


  • Cathepsin B
  • Cathepsin D
  • Endometrial Carcinoma


Dive into the research topics of 'Endometrial carcinoma expresses an increased cathepsin B/D ratio'. Together they form a unique fingerprint.

Cite this